Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer
1998

Cytokine Secretion in Colorectal Cancer Patients

Sample size: 32 publication Evidence: moderate

Author Information

Author(s): H Lahm, M Schindel, L Frikart, J-P Cerottini, A Yilmaz, J-C Givel, JR Fischer

Primary Institution: Institute of Molecular Animal Breeding, Genecenter, University of Munich

Hypothesis

The study investigates the secretion of various cytokines in whole blood cell cultures of colorectal cancer patients compared to healthy controls.

Conclusion

Colorectal cancer patients exhibit significantly lower levels of certain cytokines, which correlates with disease progression.

Supporting Evidence

  • Colorectal cancer patients secreted significantly lower amounts of IFN-a, IFN-y, IL-1 a, and IL-2 compared to healthy controls.
  • The reduction in cytokine levels correlated with the progression of the disease.
  • Lymphocyte counts were significantly lower in colorectal cancer patients, indicating a depletion of immune cells.
  • Patients with advanced stages of cancer showed the most pronounced cytokine reductions.

Takeaway

Patients with colorectal cancer have lower levels of important immune signals called cytokines, which may be linked to how advanced their cancer is.

Methodology

Blood samples were taken from healthy volunteers and colorectal cancer patients, and cytokine levels were measured after mitogen stimulation in whole blood cell cultures.

Potential Biases

Potential bias may arise from the selection of control subjects and the specific patient population studied.

Limitations

The study does not account for potential confounding factors such as previous treatments or variations in individual immune responses.

Participant Demographics

28 colorectal cancer patients (17 male, 11 female) with a mean age of 67 years, and 4 healthy volunteers with a mean age of 52 years.

Statistical Information

P-Value

p<0.0001

Confidence Interval

33.50-77.45 for IFN-a; 16525-36268 for IFN-y; 43.01-124.66 for IL-1 a; 1314-2937 for IL-2

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication